Cytogel Announces Initial Closing of Financing to Advance Lead Pain Management Candidate into Phase 2 Clinical Trials
DARIEN, CT, UNITED STATES, April 29, 2026 /EINPresswire.com/ -- Cytogel Pharma, LLC (Cytogel), a biopharmaceutical company dedicated to developing first-in-class, non-addictive treatments for moderate-to-severe pain, today announced the successful …